Metamark, BCBS of Texas Announce Agreement
News Jul 13, 2016
Metamark Genetics, Inc. has announced that it has signed an agreement with Blue Cross and Blue Shield of Texas (BCBSTX) to provide its members with in-network access to Metamark’s offering of urology specialized diagnostics.
“Metamark is delighted to be recognized as an in-network provider with Blue Cross and Blue Shield of Texas. Our continued momentum with payers across the US reflects the substantial value our comprehensive suite of products and services provides to patients, physicians, and insurers” said Jerry Williamson, president and chief executive officer.
“We maintain our strong commitment to improve the care of patients with urologic cancer by expanding access to vital, decision-making information throughout the complete diagnostic and therapeutic care journey.”
Metamark has previously announced in-network agreements with additional large Blue Cross and Blue Shield Plans and also has agreements in place with the largest PPO networks in the country.
University of Texas at Dallas scientists have demonstrated that the growth rate of the majority of lung cancer cells relates directly to the availability of a crucial oxygen-metabolizing molecule. Researchers have engineered and extensively characterized new molecules aimed at starving the cancer cells of the molecule that allows them to proliferate so quickly.